Search results
May 15, 2024 · One Japanese encephalitis vaccine (called IXIARO) is available in the United States. Japanese encephalitis vaccine is approved for use in children aged 2 months and older and adults. The vaccine should be considered for some travelers at higher risk of Japanese encephalitis.
- MMWR
Introduction. Japanese encephalitis (JE) virus, a...
- Japanese Encephalitis
Japanese encephalitis vaccine is approved for people 2...
- MMWR
May 15, 2024 · Key points. One inactivated Japanese encephalitis (JE) vaccine (manufactured as IXIARO) is available in the United States. JE vaccine is approved for use in children aged 2 months and older and adults. JE is a very low risk disease for most travelers.
Aug 15, 2019 · Japanese encephalitis vaccine is approved for people 2 months of age and older. It is recommended for people who: Plan to live in a country where JE occurs, Plan to visit a country where JE occurs for long periods (e.g., one month or more), or; Frequently travel to countries where JE occurs.
Travelers. Frequency. 2 doses 28 days apart at. least 1 week prior to travel. What is Japanese encephalitis? Japanese encephalitis is a serious infection caused by a virus present in many parts of Asia. The virus is spread between mosquitoes and animals, such as pigs and wading birds.
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. [2] The vaccines are more than 90% effective. [2] The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. [2]
The Japanese encephalitis vaccine prevents Japanese encephalitis infections. This infection causes fever, headaches and neck pain. It can also affect cognitive functioning, leading to confusion and behavior changes.
There are four main types of Japanese Encephalitis (JE) vaccines currently in use: inactivated mouse brain-based vaccines, inactivated cell-based vaccines, live attenuated vaccines, and live recombinant vaccines. JE vaccination should be integrated into national immunization schedules in all areas where JE is recognized as a public health priority.
